[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.145.218.90. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
May 1995

Laser Photocoagulation of Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

Author Affiliations

Houston, Tex

Arch Ophthalmol. 1995;113(5):554. doi:10.1001/archopht.1995.01100050016007
Abstract

Dr Yannuzzi's critique1 of the Macular Photocoagulation Study (MPS) Group guidelines2 for laser photocoagulation of subfoveal choroidal neovascularization in the April 1994 issue of the Archives is balanced and informative and comes at a time when ophthalmologists are considering the management of agerelated macular degeneration with renewed interest. Omitted, however, was a consideration of the methods employed by the MPS Group in the subfoveal trials. I am concerned that the visual results from those studies could have been influenced by placebo response.

Initial perusal of the MPS subfoveal photocoagulation reports does not suggest that a placebo effect, as described in the classic article by Beecher,3 could have influenced the test results. After all, treated patients lost, on average, 3 lines of Snellen acuity immediately following the laser barrage. On reflection, however, such an effect could have become operative later on because the clinically significant visual results were

First Page Preview View Large
First page PDF preview
First page PDF preview
×